Modulating the Blood–Brain Barrier: A Comprehensive Review
The highly secure blood–brain barrier (BBB) restricts drug access to the brain, limiting the molecular toolkit for treating central nervous system (CNS) diseases to small, lipophilic drugs. Development of a safe and effective BBB modulator would revolutionise the treatment of CNS diseases and future...
Guardado en:
Autores principales: | Rory Whelan, Grainne C. Hargaden, Andrew J. S. Knox |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/111a4f7385d448179d6db14173518d08 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of the Extracellular Traps in Central Nervous System
por: Xinyan Wu, et al.
Publicado: (2021) -
Comprehensive Mapping of the Cell Response to Borrelia bavariensis in the Brain Microvascular Endothelial Cells in vitro Using RNA-Seq
por: Zuzana Tkáčová, et al.
Publicado: (2021) -
The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
por: Joshua Yang, et al.
Publicado: (2021) -
Editorial: Bypassing the Biological Barriers by Means of Biocompatible Drug Delivery Systems
por: Vibhudutta Awasthi, et al.
Publicado: (2021) -
Robust Multi-TE ASL-Based Blood–Brain Barrier Integrity Measurements
por: Amnah Mahroo, et al.
Publicado: (2021)